NRC Health

NRC | NASDAQ

Price Alert Chart Builder DCF Calculator

$23.83

+$0.34 (+1.45%)

At close: Oct 30, 2026, 4:00 PM ET

$24.00

+$0.17 (+0.71%)

Pre-market: Nov 2, 2026, 7:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $527.11M

Enterprise Value $626.38M

Beta 0.38

Average Volume 109.97K

Shares Outstanding (Diluted) 21.89M

Shares Change YoY -3.11%

Institutional Ownership 49.84%

Exchange NASDAQ

ISIN US6373722023

Price Performance

Price Change 1M 12.5%

Price Change 3M 22.1%

Price Change 6M 36.9%

Price Change YTD 27.0%

Price Change 1Y 78.4%

Price Change 3Y -43.6%

Price Change 5Y -45.0%

1M CAGR (ann.) 16.8%

1Y CAGR (ann.) 83.2%

5Y CAGR (ann.) -8.8%

All-Time CAGR 6.8%

Valuation

PE Ratio 85.11

Forward PE 21.20

PEG Ratio -1.36

Forward PEG 2.69

PS Ratio 3.67

Forward PS 4.20

PB Ratio -57.78

P/FCF Ratio 28.57

P/Adj. FCF Ratio 68.50

P/OCF Ratio 21.86

EV/Sales 4.36

EV/EBIT 39.17

EV/EBITDA 25.57

EV/FCF 33.95

Earnings Yield 1.2%

FCF Yield 3.5%

Adj. FCF Yield 1.5%

Financial Health

Net Debt $99.27M

Total Debt $102.9M

Cash & Short-Term Investments $3.63M

Total Assets $139.21M

Current Ratio 0.64

Quick Ratio 0.64

Debt / Equity Ratio -11.28

Debt / EBITDA 4.20

Debt / FCF 5.58

OCF / Debt 0.23

Interest Coverage 2.90

Altman Z-Score 3.18

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 47.9%

Operating Profit Margin 11.1%

EBITDA Margin 17.0%

Net Profit Margin 4.5%

FCF Margin 12.8%

Adj. FCF Margin 5.3%

SBC / Revenue 7.5%

SBC Impact (per share) -58.3%

Returns

Return on Assets 4.6%

Return on Equity 103.4%

Return on Invested Capital 9.5%

Return on Capital Employed 16.3%

Return on Tangible Assets 8.8%

Historical Growth (CAGR)

Revenue CAGR 3Y -1.1%

Revenue CAGR 5Y -0.1%

Revenue CAGR 10Y 3.0%

EPS CAGR 3Y -37.7%

EPS CAGR 5Y -27.6%

EPS CAGR 10Y -5.4%

FCF CAGR 3Y -3.5%

FCF CAGR 5Y -16.4%

FCF CAGR 10Y -1.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Feb 2, 2027

EPS Estimate (next Q) $0.24

EPS Growth Est (next Q) 50.0%

Revenue Est (next Q) $38.8M

Revenue Growth Est (next Q) 10.3%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value $1.40

Lynch Upside -94.1%

Price Target $27.00

Price Target Upside 13.3%

Cash Flow

Operating Cash Flow $23.77M

Free Cash Flow $18.45M

Adj. Free Cash Flow $7.7M

FCF Per Share $0.85

OCF Per Share $1.09

OCF/S Ratio 16.5%

Income Statement

Revenue $143.79M

Gross Profit $68.84M

Operating Income $15.91M

EBITDA $24.49M

Net Income $6.44M

EPS (Diluted) $0.28

Revenue / Employee $402.76K

Profit / Employee $18.04K

Employees 357

Dividends

Annual Dividend $0.64

Dividend Yield 2.69%

Payout Ratio 228.6%

FCF Payout Ratio 73.0%

Adj. FCF Payout Ratio 175.1%

Dividend Growth (YoY) 33.3%

Pay Frequency Quarterly

Ex-Dividend Date Dec 29, 2026